The document discusses efforts to analyze food tracing data from recurring hepatitis A outbreaks in the EU/EEA. It describes how tracing back and forward exercises from affected member states were merged and analyzed to identify potential links between cases and data gaps. Two main hypotheses for the outbreak source were identified: contaminated redcurrants from Poland or blackberries from Bulgaria. Moving forward, recommendations include improving good agricultural and hygiene practices during berry production and handling, as well as vaccinating workers to prevent future outbreaks.
After several years of decreasing trend, foodborne hepatitis A virus (HAV) infection has re-emerged as a public health problem in EU/EEA since 2011. Several consecutive multi-country foodborne HAV outbreaks were experienced in Europe 2012-2014.
1) Measles and mumps vaccines have been in use for over 60 years since being developed in the 1950s and 1960s.
2) Secondary vaccine failures where vaccinated individuals get infected have been observed for measles due to waning antibody levels over time or virus evolution.
3) Recent mumps outbreaks in Europe have affected both vaccinated and unvaccinated individuals, with many cases caused by genotype G, raising questions about vaccine effectiveness.
The document discusses invasive bacterial disease (IBD) surveillance in West and Central Africa conducted by the MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine. It summarizes that the unit oversees the largest IBD surveillance network in the region, monitoring the impact of pneumococcal conjugate vaccines. Analysis of surveillance data from 2010-2016 shows declines in pneumococcal meningitis cases and deaths following vaccine introduction, though impact varies by country. Continued surveillance is needed to fully assess the effects of vaccination programs.
Overview of recent outbreaks of H5N8-High Pathogen Avian Influenza in Europe...Harm Kiezebrink
Updated outbreak assessment on Highly Pathogenic Avian Influenza: Europe, America and the Middle East. By the DEFRA, Veterinary & Science Policy Advice Team - International Disease Monitoring.
The document discusses efforts to analyze food tracing data from recurring hepatitis A outbreaks in the EU/EEA. It describes how tracing back and forward exercises from affected member states were merged and analyzed to identify potential links between cases and data gaps. Two main hypotheses for the outbreak source were identified: contaminated redcurrants from Poland or blackberries from Bulgaria. Moving forward, recommendations include improving good agricultural and hygiene practices during berry production and handling, as well as vaccinating workers to prevent future outbreaks.
After several years of decreasing trend, foodborne hepatitis A virus (HAV) infection has re-emerged as a public health problem in EU/EEA since 2011. Several consecutive multi-country foodborne HAV outbreaks were experienced in Europe 2012-2014.
1) Measles and mumps vaccines have been in use for over 60 years since being developed in the 1950s and 1960s.
2) Secondary vaccine failures where vaccinated individuals get infected have been observed for measles due to waning antibody levels over time or virus evolution.
3) Recent mumps outbreaks in Europe have affected both vaccinated and unvaccinated individuals, with many cases caused by genotype G, raising questions about vaccine effectiveness.
The document discusses invasive bacterial disease (IBD) surveillance in West and Central Africa conducted by the MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine. It summarizes that the unit oversees the largest IBD surveillance network in the region, monitoring the impact of pneumococcal conjugate vaccines. Analysis of surveillance data from 2010-2016 shows declines in pneumococcal meningitis cases and deaths following vaccine introduction, though impact varies by country. Continued surveillance is needed to fully assess the effects of vaccination programs.
Overview of recent outbreaks of H5N8-High Pathogen Avian Influenza in Europe...Harm Kiezebrink
Updated outbreak assessment on Highly Pathogenic Avian Influenza: Europe, America and the Middle East. By the DEFRA, Veterinary & Science Policy Advice Team - International Disease Monitoring.
Professor Michael Levin's presentation at Meningitis Research Foundation's 2013 conference Meningitis & Septicaemia in Children & Adults www.meningitis.org/conference2013
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
Antimicrobial resistance is a growing global threat as many modern medicines may lose effectiveness against common bacterial infections. The overuse and misuse of antibiotics in humans and animals is driving increased resistance worldwide. Finland has one of the lowest rates of antimicrobial resistance in Europe due to early and collaborative efforts between human and veterinary sectors to prudently use antibiotics and prevent infectious diseases. However, imported resistant bacteria remain a risk, and all countries must continue efforts to implement guidelines on prudent antibiotic use, increase awareness, and engage in international cooperation to address this global challenge.
This document discusses the introduction of two new meningococcal immunization programs in England, including vaccination against meningococcal group B disease. It provides data on trends in meningococcal disease cases over time, outlines the age distribution of invasive meningococcal disease, and discusses the role of serogroup B vaccines in the UK. It summarizes evidence from clinical trials demonstrating the immunogenicity and tolerability of the MenB vaccine Bexsero, and reviews data showing that prophylactic paracetamol can reduce fever following vaccination without impacting the vaccine's immunogenicity.
Hepatitis E surveillance in Sweden involves the notification and reporting of suspected and confirmed hepatitis E cases to the national surveillance database SmiNet hosted by the Public Health Agency of Sweden. Clinicians and diagnostic laboratories report clinical and laboratory data on notified cases, including demographic, epidemiological, and diagnostic testing information. The County Medical Officer is responsible for contact tracing notified cases to identify potential transmission routes. Between 1997-2015, 173 hepatitis E cases were notified in Sweden, with most being travel-related and acquired through food or water. Studies show hepatitis E virus RNA has been detected in pigs, wild boars, and moose in Sweden, with genetic sequencing linking some human strains to those found in local animals.
This document discusses the ongoing issue of antimicrobial resistance in Europe. It provides data from surveillance networks showing high levels of resistance to certain antibiotics in some countries. For example, resistance to last-line antibiotics in Klebsiella pneumoniae is causing concern. The document also shows increasing trends in carbapenem use in hospitals from 2009-2013. It emphasizes the importance of antimicrobial stewardship, infection prevention and control, and developing new antibiotics to address the public health threat of antimicrobial resistance.
This document summarizes a workshop on tackling antimicrobial resistance held in Bristol, England. The workshop covered national actions and strategies to address AMR, including the UK's 5-year AMR strategy with 7 key areas of action. It discussed improved surveillance of antibiotic use and resistance in England, as well as initiatives to optimize antibiotic prescribing and antimicrobial stewardship. The workshop emphasized the role of all stakeholders in addressing AMR and highlighted ongoing work in the South West of England to tackle AMR through various programs and collaborations.
This document summarizes the epidemiology and surveillance of meningococcal disease in England. It describes the mature surveillance system that has been in place since 1984 and involves cooperation between reference laboratories, epidemiologists, and immunization colleagues. The surveillance is supported by microbiology laboratories across England and Public Health England health protection teams. The comprehensive dataset collected allows for characterization of cultures and whole genome sequencing of invasive meningococcal disease cultures since 2010. The data show a rapid reduction in group C meningococcal disease following vaccination but an increase in group W disease since 2009. Surveillance is essential to monitor changes in meningococcal populations, support vaccine development and evaluation, and modify immunization schedules.
Dr Marie-Pierre Preziosi's presentation at Meningitis Research Foundation's 2013 conference, Meningitis & Septicaemia in Children & Adults http://www.meningitis.org/conference2013
This study used TaqMan Array Cards (TAC) to test cerebrospinal fluid (CSF) samples from suspected meningitis cases in five West African countries. TAC detected pathogens in 20% of samples, a ten-fold increase over standard methods. Pneumococcus remained common but gram-negative bacteria like E. coli and Klebsiella pneumoniae were also frequently identified, particularly in neonates. Viruses including enterovirus, parvovirus, dengue, and HIV were also detected. HIV and Plasmodium infections were associated with higher mortality. TAC has potential for improving meningitis surveillance and monitoring vaccine impact and antimicrobial resistance in the region.
The National Audit of Meningitis Management (NAMM) analyzed data from 1,472 patients with bacterial or viral meningitis from 64 UK hospitals in 2017. The audit found that clinical care is not fully adhering to UK guidelines for meningitis management. Only 50% of patients had blood cultures taken within 1 hour of arrival and only 2% had a lumbar puncture within 1 hour. Adjunctive steroids were only given to 26% of patients. The audit results indicate there is significant room for improvement in adhering to guidelines regarding timely diagnostic testing, use of antibiotics and steroids, and meningitis management overall.
Current epidemiology of meningococcal disease in the African meningitis belt and new WHO outbreak response guidelines after the Meningitis Vaccine Project
http://www.meningitis.org/conference2015
- A new low-cost 10-valent pneumococcal conjugate vaccine (PCV) has been developed by the Serum Institute of India (SIIPL). Phase 3 clinical trials found non-inferior immunogenicity compared to Synflorix for the matched serotypes. WHO prequalification is anticipated.
- While current PCVs provide good protection, gaps remain in serotype coverage, cost, and impact on nasopharyngeal carriage. Higher valency PCVs face challenges in manufacturing complexity.
- Several pneumococcal protein vaccines have shown promise in preclinical studies but efficacy has not yet been proven in clinical trials. A Phase 2 trial of two proteins co-administered with PCV
This document reports a case of atypical Bovine Spongiform Encephalopathy (BSE), type H, detected in Brazil. The case involved an 11-year-old beef cow from a farm in Mato Grosso that was submitted for emergency slaughter. Testing at the national reference laboratory confirmed the presence of prion antigens. This is the fifth case of atypical BSE identified in Brazil since surveillance began 23 years ago. Control measures were implemented, including removal and destruction of specified risk materials. The investigation of this isolated event has concluded.
This document reports a case of atypical Bovine Spongiform Encephalopathy (BSE) detected in Brazil. The case was detected in a 10-year old beef cow that was slaughtered in Pernambuco state. Testing confirmed the case was an atypical BSE type H. This is the fourth case of atypical BSE identified in Brazil since surveillance began 23 years ago, with the last previous case in 2019. An investigation found the source of infection was unknown. Control measures were applied including removal and destruction of specified risk materials.
Pipeline or pipe dream - Midlands Micro Meeting UK - mon 15 sep 2014Torsten Seemann
This document summarizes a presentation about transitioning a public health microbiology laboratory from traditional bacterial typing methods like PFGE to whole genome sequencing (WGS) and bioinformatics. Key points include:
1) WGS allows for higher resolution analysis of bacterial isolates compared to traditional methods and can identify genomic variations, plasmids, and resistance/virulence genes.
2) Implementing WGS requires developing automated pipelines for processing large volumes of sequencing data using techniques like read mapping, de novo assembly, and k-mer analysis.
3) The goals are to modernize operations, increase research output, and develop shared online systems and data sharing between laboratories internationally.
Professor Michael Levin's presentation at Meningitis Research Foundation's 2013 conference Meningitis & Septicaemia in Children & Adults www.meningitis.org/conference2013
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
Antimicrobial resistance is a growing global threat as many modern medicines may lose effectiveness against common bacterial infections. The overuse and misuse of antibiotics in humans and animals is driving increased resistance worldwide. Finland has one of the lowest rates of antimicrobial resistance in Europe due to early and collaborative efforts between human and veterinary sectors to prudently use antibiotics and prevent infectious diseases. However, imported resistant bacteria remain a risk, and all countries must continue efforts to implement guidelines on prudent antibiotic use, increase awareness, and engage in international cooperation to address this global challenge.
This document discusses the introduction of two new meningococcal immunization programs in England, including vaccination against meningococcal group B disease. It provides data on trends in meningococcal disease cases over time, outlines the age distribution of invasive meningococcal disease, and discusses the role of serogroup B vaccines in the UK. It summarizes evidence from clinical trials demonstrating the immunogenicity and tolerability of the MenB vaccine Bexsero, and reviews data showing that prophylactic paracetamol can reduce fever following vaccination without impacting the vaccine's immunogenicity.
Hepatitis E surveillance in Sweden involves the notification and reporting of suspected and confirmed hepatitis E cases to the national surveillance database SmiNet hosted by the Public Health Agency of Sweden. Clinicians and diagnostic laboratories report clinical and laboratory data on notified cases, including demographic, epidemiological, and diagnostic testing information. The County Medical Officer is responsible for contact tracing notified cases to identify potential transmission routes. Between 1997-2015, 173 hepatitis E cases were notified in Sweden, with most being travel-related and acquired through food or water. Studies show hepatitis E virus RNA has been detected in pigs, wild boars, and moose in Sweden, with genetic sequencing linking some human strains to those found in local animals.
This document discusses the ongoing issue of antimicrobial resistance in Europe. It provides data from surveillance networks showing high levels of resistance to certain antibiotics in some countries. For example, resistance to last-line antibiotics in Klebsiella pneumoniae is causing concern. The document also shows increasing trends in carbapenem use in hospitals from 2009-2013. It emphasizes the importance of antimicrobial stewardship, infection prevention and control, and developing new antibiotics to address the public health threat of antimicrobial resistance.
This document summarizes a workshop on tackling antimicrobial resistance held in Bristol, England. The workshop covered national actions and strategies to address AMR, including the UK's 5-year AMR strategy with 7 key areas of action. It discussed improved surveillance of antibiotic use and resistance in England, as well as initiatives to optimize antibiotic prescribing and antimicrobial stewardship. The workshop emphasized the role of all stakeholders in addressing AMR and highlighted ongoing work in the South West of England to tackle AMR through various programs and collaborations.
This document summarizes the epidemiology and surveillance of meningococcal disease in England. It describes the mature surveillance system that has been in place since 1984 and involves cooperation between reference laboratories, epidemiologists, and immunization colleagues. The surveillance is supported by microbiology laboratories across England and Public Health England health protection teams. The comprehensive dataset collected allows for characterization of cultures and whole genome sequencing of invasive meningococcal disease cultures since 2010. The data show a rapid reduction in group C meningococcal disease following vaccination but an increase in group W disease since 2009. Surveillance is essential to monitor changes in meningococcal populations, support vaccine development and evaluation, and modify immunization schedules.
Dr Marie-Pierre Preziosi's presentation at Meningitis Research Foundation's 2013 conference, Meningitis & Septicaemia in Children & Adults http://www.meningitis.org/conference2013
This study used TaqMan Array Cards (TAC) to test cerebrospinal fluid (CSF) samples from suspected meningitis cases in five West African countries. TAC detected pathogens in 20% of samples, a ten-fold increase over standard methods. Pneumococcus remained common but gram-negative bacteria like E. coli and Klebsiella pneumoniae were also frequently identified, particularly in neonates. Viruses including enterovirus, parvovirus, dengue, and HIV were also detected. HIV and Plasmodium infections were associated with higher mortality. TAC has potential for improving meningitis surveillance and monitoring vaccine impact and antimicrobial resistance in the region.
The National Audit of Meningitis Management (NAMM) analyzed data from 1,472 patients with bacterial or viral meningitis from 64 UK hospitals in 2017. The audit found that clinical care is not fully adhering to UK guidelines for meningitis management. Only 50% of patients had blood cultures taken within 1 hour of arrival and only 2% had a lumbar puncture within 1 hour. Adjunctive steroids were only given to 26% of patients. The audit results indicate there is significant room for improvement in adhering to guidelines regarding timely diagnostic testing, use of antibiotics and steroids, and meningitis management overall.
Current epidemiology of meningococcal disease in the African meningitis belt and new WHO outbreak response guidelines after the Meningitis Vaccine Project
http://www.meningitis.org/conference2015
- A new low-cost 10-valent pneumococcal conjugate vaccine (PCV) has been developed by the Serum Institute of India (SIIPL). Phase 3 clinical trials found non-inferior immunogenicity compared to Synflorix for the matched serotypes. WHO prequalification is anticipated.
- While current PCVs provide good protection, gaps remain in serotype coverage, cost, and impact on nasopharyngeal carriage. Higher valency PCVs face challenges in manufacturing complexity.
- Several pneumococcal protein vaccines have shown promise in preclinical studies but efficacy has not yet been proven in clinical trials. A Phase 2 trial of two proteins co-administered with PCV
This document reports a case of atypical Bovine Spongiform Encephalopathy (BSE), type H, detected in Brazil. The case involved an 11-year-old beef cow from a farm in Mato Grosso that was submitted for emergency slaughter. Testing at the national reference laboratory confirmed the presence of prion antigens. This is the fifth case of atypical BSE identified in Brazil since surveillance began 23 years ago. Control measures were implemented, including removal and destruction of specified risk materials. The investigation of this isolated event has concluded.
This document reports a case of atypical Bovine Spongiform Encephalopathy (BSE) detected in Brazil. The case was detected in a 10-year old beef cow that was slaughtered in Pernambuco state. Testing confirmed the case was an atypical BSE type H. This is the fourth case of atypical BSE identified in Brazil since surveillance began 23 years ago, with the last previous case in 2019. An investigation found the source of infection was unknown. Control measures were applied including removal and destruction of specified risk materials.
Pipeline or pipe dream - Midlands Micro Meeting UK - mon 15 sep 2014Torsten Seemann
This document summarizes a presentation about transitioning a public health microbiology laboratory from traditional bacterial typing methods like PFGE to whole genome sequencing (WGS) and bioinformatics. Key points include:
1) WGS allows for higher resolution analysis of bacterial isolates compared to traditional methods and can identify genomic variations, plasmids, and resistance/virulence genes.
2) Implementing WGS requires developing automated pipelines for processing large volumes of sequencing data using techniques like read mapping, de novo assembly, and k-mer analysis.
3) The goals are to modernize operations, increase research output, and develop shared online systems and data sharing between laboratories internationally.
A peek inside the bioinformatics black box - DCAMG Symposium - mon 20 july 2015Torsten Seemann
An introduction to basic genomics bioinformatics concepts in 20 minutes for an audience of clinicians, epidemiologists and other public health officials.
Visualizing the pan genome - Australian Society for Microbiology - tue 8 jul ...Torsten Seemann
Invited talk at the Australian Society for Microbiology Annual Conference 2014 on "FriPan" our tool for visualizing bacterial pan genomes across 10-100s of isolates.
Rapid automatic microbial genome annotation using Prokka
Dr Torsten Seemann presents on Prokka, a tool he developed for rapid automatic annotation of microbial genomes. Prokka uses existing gene prediction tools like Prodigal and Infernal along with database searches to identify features like protein coding genes, tRNAs, and rRNAs. Prokka aims to annotate genomes quickly in under 15 minutes while providing standardized GFF3 and Genbank output files along with provenance on the sources of annotations. Prokka has been used to annotate over 50,000 draft genomes and is an ongoing project aimed at improving accuracy, modularity, and performance.
Snippy - Rapid bacterial variant calling - UK - tue 5 may 2015Torsten Seemann
Using Snippy to call variants in bacterial short read datasets via alignment to reference, and then using these alignments to produce core SNP alignments for phylogenomics.
This document summarizes a presentation on using whole genome sequencing (WGS) for rapid characterization of bacterial outbreaks. The presenter discusses transitioning public health labs from traditional typing methods to WGS-based approaches. Key points include developing automated analysis pipelines to identify bacteria, determine antimicrobial resistance and virulence genes, and construct phylogenomic trees from core genome SNPs. The goal is a cloud-based system allowing labs to securely upload and analyze sequencing data with open source tools integrated in modular pipelines.
This document summarizes Ireland's experience with Hepatitis E virus (HEV) from 2016-2018. Key points include:
- HEV became a notifiable disease in Ireland in 2015 and universal blood donor screening began in 2016.
- Between 2016-2017, there were 90 and 54 HEV notifications respectively, with the majority of cases detected through blood screening and the rest from clinical cases.
- Enhanced surveillance of clinical cases from 2016-2017 found the highest risk factors were consumption of pork products and shellfish.
- The FoVIRA study aims to investigate HEV and other foodborne viruses in the Irish food chain from farm to fork to identify risks and mitigation approaches.
Institut Pasteur: An International Partner To Implement One Health Maria VA...Global Risk Forum GRFDavos
The Institut Pasteur has a long history of implementing a One Health approach to address emerging infectious diseases. It has worked jointly with animal and human health sectors on diseases such as rabies, H5N1, and MERS-CoV through activities like field investigations, laboratory training, and vaccine development. While One Health approaches have been adopted in policies, local implementation remains a challenge due to issues like limited resources, sectoral barriers, and communication difficulties. The Institut Pasteur aims to strengthen One Health by expanding multisectoral collaborations during outbreak responses and translating findings into improved public health protocols.
This document summarizes the test-negative design study conducted by the Istituto Superiore di Sanità (National Institute of Health, ISS) within the Italian Influenza surveillance network (InfluNet) during the 2018-2019 influenza season. The study aimed to estimate seasonal influenza vaccine effectiveness against laboratory-confirmed influenza in Italy. A total of 2,526 patients presenting with influenza-like illness to participating general practitioners were enrolled. Of those, 1,177 tested positive for influenza and 1,349 tested negative. Preliminary results found significant differences in age distribution between cases and controls, with a higher proportion of cases among children and the elderly. Further analyses will estimate vaccine effectiveness stratified by age, virus subtype, and
Trends on Health-Care Associated Infections and Infection Control in Estonia ...Kazimierz Murzyn
Presentation given during Cost AMiCI meeting in Tallinn Nov 2017
by Pille Märtin
Infection control doctor
West-Tallinn Central Hospital
Chief specialist
Dep. Of Communicable Diseases surveillance and control
Health Board of Estonia
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...THL
Ms. Johanna Takkinen, Head of Food and Waterborne Diseases and Zoonoses Programme, ECDC, at One Health Security Conference, 14-15 Oct 2019, THL, Helsinki
Basic laboratory procedures in clinical bacteriologyamin beni
book of Basic laboratory procedures in clinical bacteriology Basic laboratory procedures in clinical bacteriology Basic laboratory procedures in clinical bacteriology Basic laboratory procedures in clinical bacteriology
AUSVET-REMESA Workshop - Situation de la fièvre aphteuse (FA) en Afrique du N...EuFMD
The document summarizes the foot-and-mouth disease (FMD) situation in North Africa over the last 4 years, with a focus on Tunisia. It describes FMD outbreaks that occurred in Tunisia in 2014, 2017, and 2018-2019. In 2014, there were 150 total outbreaks across Tunisia. In 2017, two outbreaks occurred in Bizerte in April and May, linked to the introduction of animals from a local market. Measures taken included vaccination campaigns, increased surveillance, and improved biosecurity. From December 2018 to March 2019, there were 14 outbreaks affecting cattle and small ruminants in 5 governorates. Border control measures and vaccination strategies are also discussed.
GHME 2013 Conference
Session: Global and national Burden of Disease II
Date: June 17 2013
Presenter: Arie Havelaar
Institute:
National Institute for Public Health and the Environment
Pestforecast: Surveillance and early warning systems for climate sensitive di...ILRI
Presentation by Hu Suk Lee at the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) annual meeting in Southeast Asia, Hanoi, Vietnam, 30 November 2016.
Monica Olsen (National Food Agency of Sweden) Risk Benefit Assessment
Roundtable of aflatoxin experts on
“Building a multi-stakeholder approach to mitigate aflatoxin contamination of food and feed”
Brussels, Monday 25th January 2016
A recent Presentation at National Annual Review Meeting of Core Group Polio Project (CGPP) -USAID funded project, ADRA India: implementing agency with technical support from CORE Secretariat
The document discusses global polio updates, the polio endgame plan, and health systems strengthening in India. It provides statistics showing a reduction in wild poliovirus cases globally. It outlines plans for the global switch from trivalent to bivalent oral polio vaccine and strengthening surveillance. The polio eradication strategic plan aims to stop all poliovirus transmission by 2018. In India, polio resources and infrastructure are being transitioned to strengthen routine immunization and support other health priorities through initiatives like Mission Indradhanush.
The document provides updated guidelines from the European Academy of Allergy and Clinical Immunology (EAACI) for the diagnosis, management, and prevention of anaphylaxis. Key points addressed in the guidelines include:
1) Recommending the use of clinical criteria to identify anaphylaxis and blood sampling for measurement of tryptase levels.
2) Prompting the use of intramuscular adrenaline as first-line management and ensuring availability of adrenaline autoinjectors for patients at risk.
3) Suggesting structured training for individuals at risk of anaphylaxis and simulation training for healthcare professionals to improve management of anaphylactic reactions.
Dr. Tom Chiller - International Activities in Antimicrobial ResistanceJohn Blue
International Activities in Antimicrobial Resistance - Dr. Tom Chiller, Associate Director for Epidemiologic Science, Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
This document summarizes surveillance and studies of Hepatitis E virus (HEV) in Portugal. It describes Portugal's national surveillance system for HEV, including case definitions and mandatory reporting. Laboratory diagnostic methods for HEV detection are also outlined. Several studies on HEV in the Portuguese population and animal reservoirs are summarized, including seroprevalence studies in various groups ranging from 9-14% and case reports of HEV genotype 3 infection. Studies also detected HEV RNA in 22% of pig faeces tested, indicating pigs may be a reservoir of zoonotic HEV in Portugal. Ongoing research includes a population study evaluating HEV risk from porcine pharmaceutical products.
This document provides an overview of Hong Kong's food safety framework and incidents relating to food additives. It describes the organization of the Food and Environmental Hygiene Department and the Centre for Food Safety, which oversees food surveillance programs. The legal framework for regulating food additives is also outlined. Recent surveillance results from 2011-2013 found some meat, vegetable and fruit samples containing excessive levels of preservatives like sulphur dioxide. Case examples are also presented, such as the detection of sulphur dioxide in some meat intended for raw consumption. The overall compliance rate for food additive regulations has improved according to the trend data shown.
Similar to Recurring hepatitis A outbreaks in the EU/EEA: a national perspective, Dr. Gaia Scavia (20)
- There were 49,752 TB cases notified in 29 EU/EEA countries in 2019, with a notification rate of 9.6 per 100,000 population. The number and rate of TB cases have declined steadily between 2010-2019.
- Males had higher notification rates than females across all age groups over 14. The highest rate was in those aged 25-44.
- 34.5% of cases were in persons of foreign origin, up from 25.3% in 2010.
- Treatment success rates after 12 months of treatment declined from 76.2% in 2009 to 63.7% in 2018.
Summary slides on the epidemiological situation in the EU/EEA.
2018 surveillance data.
Report and ppt slides available from: http://bit.ly/HIVAIDSsurv18
The document summarizes the status of pre-exposure prophylaxis (PrEP) implementation in Europe based on data from 2018-2019. It finds that while formal PrEP rollout has been slow, especially in Eastern Europe and Central Asia, there is evidence of significant informal PrEP use across countries. As a result, an estimated 500,000 men who have sex with men (MSM) want or need PrEP but are unable to access it, representing a "PrEP gap" in Europe. Barriers to wider PrEP implementation include cost and lack of public funding in some countries.
Presentation from the opening session of the 17th European AIDS Conference (EACS) 2019, Basel, Switzerland.
Presenter: Anastasia Pharris, European Centre for Disease Prevention and Control.
ECDC symposium "Responding to two of the main STI threats of our time: syphilis and antimicrobial resistant Neisseria gonorrhoeae"
Presentation by: Otilia Mårdh
Presented at: IUSTI 2019, Tallinn
1) Hepatitis E virus (HEV) infection has emerged as an important public health issue in Europe, with over 21,000 cases reported between 2005-2015 across EU/EEA countries.
2) Surveillance systems and case definitions for HEV vary between countries, but most (20/30) now have specific national surveillance for HEV in place.
3) The majority (98%) of HEV cases in Europe are now locally acquired rather than travel-associated, and over half of all cases are diagnosed in hospitals.
This presentation summarises the main data from the ECDC Annual epidemiological reports 2017 on chlamydia, gonorrhoea, lymphogranuloma venereum, (congenital) syphilis
This document summarizes a presentation on estimating mortality due to viral hepatitis using attributable fractions. It discusses:
1) The WHO reference method which uses national mortality statistics and attributable fraction estimates from GBD to estimate hepatitis-related deaths.
2) A sentinel pilot study conducted in Bulgaria and Portugal to develop local estimates of the attributable fractions of cirrhosis and liver cancer caused by hepatitis B and C. The pilot found the attributable fractions varied between sites.
3) Outcomes from the pilot included improved local mortality estimates and lessons learned for expanding the methodology to other countries through clinical and public health partnerships. Limitations around representing overall populations and assigning morbidity to mortality were also noted.
Providing an overview on data, trends and summary of findings on the hepatitis B and C surveillance data from EU/EEA countries for the year 2017:
Find ECDC's Annual Epidemiological reports online: http://bit.ly/ECDCAER
Respondent Driven Sampling (RDS) is a technique for sampling hard-to-reach populations. It works by having initial participants (seeds) recruit a small number of people from their social networks, who are then eligible to recruit others from their networks. This process continues in successive waves. RDS relies on assumptions about network structure and recruitment behaviors. Analysis adjusts for network size and recruitment patterns. The technique was used to sample migrants in Morocco to estimate HIV, syphilis, and tuberculosis prevalence and understand their demographics, risks, and access to services. Results provided insights to guide health programs for this population.
The document summarizes HIV/AIDS surveillance data in Europe for 2017. Some key findings are:
- 25,353 new HIV diagnoses were reported in 30 EU/EEA countries in 2017.
- Sex between men accounted for 38% of new diagnoses, while heterosexual transmission accounted for 33%.
- Nearly half (49%) of individuals were diagnosed late, with a CD4 count below 350 cells/mm3.
- Migrants accounted for 41% of new diagnoses, many originating from sub-Saharan Africa and Latin America.
This document summarizes a presentation given by Anastasia Pharris of the European Centre for Disease Prevention and Control on infections among people who inject drugs. It finds that over 30,000 new HIV diagnoses in Europe in 2016 were due to injecting drug use, with most cases concentrated in Eastern Europe. While harm reduction efforts have made progress in some countries, people who inject drugs still face high burdens of HIV, hepatitis C, and other infections. The presentation calls for improved testing, treatment, and prevention programs targeting this group.
What is the current situation of HIV in Europe and Central Asia?
How can we more effectively prevent new infections?
Presentation by Anastasia Pharris,
European Centre for Disease Prevention and Control (ECDC)
at Glasgow HIV Drug Therapy Conference
28 October 2018
Data and trends from the ECDC Annual Epidemiological reports for 2016 on:
Chlamydia (http://bit.ly/AERch16)
Lymphogranuloma venereum (http://bit.ly/AERLGV16)
Gonorrhoea (http://bit.ly/AERsy16)
Syphilis (http://bit.ly/AERsy16)
Congenital syphilis (http://bit.ly/AERcs16)
See also: https://ecdc.europa.eu/en/annual-epidemiological-reports
1) 58,994 TB cases were notified in 30 EU/EEA countries in 2016, with a notification rate of 11.4 per 100,000 population. The number and rate of TB cases have declined continuously between 2007-2016.
2) The highest notification rates in 2016 were among those aged 25-44, and males had higher rates than females in all groups over 14. Rates have declined annually by 2-4% in all age groups between 2007-2016.
3) 32.7% of cases in 2016 were in persons of foreign origin, an increase from 21% in 2007. The rate of cases in foreign-born persons was stable between 2007-2016.
Teymur Noori, ECDC
22nd International AIDS Conference, Amsterdam 2018
2018 European African HIV/AIDS & Hepatitis C Community Summit. "Our Voices Matter for a lasting solution!!"
More from European Centre for Disease Prevention and Control (20)
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Recurring hepatitis A outbreaks in the EU/EEA: a national perspective, Dr. Gaia Scavia
1. Recurring hepatitis A outbreaks in the
EU/EEA: a national perspective
Gaia Scavia (DVM)
Istituto Superiore di Sanità
Dep. Veterinary Public Healyh
and Food Safety
Rome, Italy
gaia.scavia@iss.it
ESCAIDE – European Scientific Conference on Applied
Infectious Diseases Epidemiology 2015
Stockholm, 12 November 2015
2. Incidence <3 x 100000
Incidence 3-6 x 100000
Incidence 6-9 x 100000
Incidence >9 x 100000
Data not available for seieva
Provinceof
Trento
Outbreak of Hepatitis A in Italy, 2013-2014:
The final numbers (1) - Epidemic cases 0f Hepatitis A
• 1438 cases of HAV infection reported continuosly
between 1 January 2013 and 31 August 2014, all
over the country
•369 cases (25% of the cases reported) with
sequencing of HAV performed
•247 confirmed cases (67% of all sequenced cases)
with HAV outbreak strain (HAV gen IA, KF182323)
•Characteristics of cases:
Median age: 33 yrs
54,8%: Males
86,3%: hospitalized (median duration 7 days)
1 death
•Consumption of frozen berries reported by 52,6%
of possible cases and by 78,2% of confirmed cases
Incidence <3 x 100000
Incidence 3-6 x 100000
Incidence 6-9 x 100000
Incidence >9 x 100000
Data not available for seieva
FriuliVenezia
Giulia
Apulia
Emilia
Romagna
Provinceof
Trento
Province of
Bolzano
Frozen berries was the suspect vehicle
3. 161 outbreak sequences
(100% nt intragroup identity
460 base pairs at the region
of VP1/2A)
genotype IA
86 sequences genotype IA
highly related to the outbreak
sequence (a shorter fragment of 174
base pairs at the region of VP1/2A)
90sequences unrelated to
the "outbreak" sequence
(93-96% nt identity)
genotype IA
29 sequences
(89.4-93.4% nt identity)
genotype IB
Data source: National Reference Laboratory, ISS
Strong
evidence
1 frozen berry mix
outbreak sequence
(100% nt identity region
VP1/2A) genotype IA
Strong microbiological evidence:
Genotyping and sequencing of HAV (VP1/2A region)
from 369 patients with HA (April 2013 – Jan 2014)
4. Probable + confirmed cases (n=119) Confirmed cases only (n=24)
Montano-Remacha C. et al. Eurosurveillance 2014;19(37):pii=20906.
Strong epidemiological evidence:
Matched Case-Control Study: 119 cases and 419 control
Strong
evidence
5. Ministry of Health (MoH):
•Dir. Public Health and Prevention
•Dir. Veterinary Public Health and Food Safety
National Public Health Institute (ISS)
•ECDC contact point for FWD – EFSA Focal Point
•Hepatitis A dedicated surveillance SEIEVA
•Monitoring of outbreak cases of HAV
•Coordination of case control study
•Molecular characterization of HAV (National Ref. Lab for
Hepatitis)
•Development of guideline for frozen berry sampling and
testing for HAV
•Validation of method ISO/TS 15216-1:2013 for detection of
HAV in food
•Tracing-back analysis on the food supply chain
•Inspection to the food processing plants
• Food Safety Laboratory (IZSLER)
• Testing food for HAV contamination
• Molecular characterization of HAV from berries
The National Task force for the Hepatitits A
Support to the Local Health Authorities (ASL) which are the competent
authorities at the territorial level (See Reg. EC/178/2002)
6. Outbreak of HA in Italy: how it all began
EPIS - 8 May: Urgent Inquiry
posted by Germany in EPIS
ISS - April: national alert about
HA outbreaks in North Europe
and tourists from Egypt
EWRS - 9 May: Alert
posted by Poland
ISS - 8 May: EPIS Alert
forwarded to MoH and regions
RASFF (Italy) - 17 May: HAV
detected in frozen mixed berries
ASL-TN- 10 May: Mixed frozen
berries were suspected as vehicle
of HAV- tracing-back; sampling
ASL 13 May : other clusters
of HA cases reported
ISS - 14 May: Italy reply
posted in EPIS
ISS – 13, 16 May: Joint
report to the MoH
ECDC – EFSA 23 May:
First Hepatitits A
Rapid Outbreak
Assessment, Italy
IZSLER - 22 May: Two lots of
frozen mixed berries
connected with cases in TN
province positive for HAV
ISS - 22 May:
Case-Control
study drafted
MoH - 23 May: National
outbreak declared:
- Joint enhanced
molecular-based
surveillance launched.
- Start of berries tracing
back activities
RASFF (Italy) – 30
May: (756 - 757)
HAV detected in
frozen mixed berries
connected with the
German tourists
NumberofcasesofHepatitisA
Strong evidence that
frozen berries were the vehicle
of HAV infection
was obtained in 14 days !
7. Outbreak of Hepatitis A in Italy, 2013-2014:
Control measures adopted during the outbreak
• All the contaminated frozen berry lots were
withdrawn and recalled from the market
• Communication to consumers on the risk of
consuming frozen berries raw
• Guidance to frozen berry sampling
• Testing for HAV soon introduced in HACCP control
plans
• Trace-back of the frozen berries suppliers
The preliminary trace-back analysis of the HAV
contaminated lots (RASFF 694-756-757) showed
that all the ingredients had been imported,
indicating the potential for a multinational
dimension of the outbreak !
8. The Food Safety Legal Framework
• Regulation (EC) 178/2002:
Article 14: Unsafe food shall not be placed on the market
Article 53: Where it is evident that food is likely to constitute a serious risk
to human health, suspension of the placing on the market or use of the
food in question
Case-by-case risk assessment
Outbreak of HA in Italy: how it continued
• Regulation (EC) No 882/2004:
Safeguard Measure, Article 56
Conditions for application of Art.53
of Reg. (EC)/178/2002 within the EU
How to adopt more robust control measures against the risk of
HAV contamination in the frozen berry chain?
9. RASFF 694
756, 757 880, 1087
1229
1134, 1350
1350 1403
Start of EFSA tracing back
EFSA tracing-back published
20142013
SamplesoffrozenberrytestedforHAV
Weekly distribution of frozen berry tested for HAV in Italy, 2013-2014 (n=1982)
Frozen berry food chain:
characterization of the risk of HAV contamination
•Testing frozen berries at retail and at processing
•Tracing-back of frozen berry suppliers
16 months to complete the tracing back exercise!
10. Frozen berry food chain: prevalence of contamination
with HAV and lots connected with the outbreak
•1982 samples of frozen berries
tested for HAV between April 2013
and October 2014
• 62 lots from 13 packaging
companies (brands) located in 5
countries were connected with the
outbreak
15 lots contaminated with HAV
(0,8% of total samples tested)
47 suspect lots: identified only
based on cases’ interviews only
•34 lots with investigation of the
supplying chain traced-back
11. •34 lots traced-back
•1691 transactions traced-back
• 57 transactions on average, per lot
(range: 3–103)
• 406 suppliers from 19 countries
• Only 1 Italian primary supplier
• Explored hypotheses:
Pre-harvest primary
contamination
Post Harvest: Cross
contamination across the
food supplying chain
Tracing back in Italy: characterization of the food supply chain
12. Numberoflots
20132012 2014 2015
Lots of frozen berry connected with the outbreak, by date of packaging (n=62)
Shelf Life of frozen berries 24 months
Frozen berry food chain: estimated period of presence of HAV
contaminated lots on the the Italian market
contamination present on the market from 2012 to 2015!!
13. • Frozen berries are associated with an important public health risk:
• Very high risk profile: when consumed raw, frozen berries are ready-to-eat
products
• When contamination occur in the preharvest phase there are no points for
risk mitigation before the consumers
• Once frozen they have a prolonged shelf-life, are easily traded with the
potential of spreading infectivity worlwide
• Need for improving tracing back timeliness and compliance by MSs
• Several pieces of evidence concerning the risk profiling of frozen berries have
been produced through the investigation of the HA outbreak in Italy
• Update of the Risk Assessment of food of non animal origin (including NoV
and HAV in frozen berries) carried out by EFSA (EFSA Journal 2014:12
(6):3706) preliminary and necessary step for the adoption of a
microbiological criterion according to general EU food safety regulations
• Close multidisciplinary collaboration, prepardness and harmonization
across sectors are the key-tools for facing foodborne outbreak crisis
Conclusions
14. Acknowledgments
The Italian National Task Force for Hepatits A
Istituto Superiore di Sanità (ISS)
Dep. Veterinary Public Health and Food Safety
M Escher, L Busani, D De Medici, S Di Pasquale, G Scavia,
National Centre for Epidemiology, Surevillance and Health Promotion
C Rizzo, V Alfonsi, L Ricotta, MC Montaño-Remacha, E Tosti Maria
Dep. of Infectious Diseases
AR Ciccaglione, S Taffon, R Bruni, M Equestre
Ministero della Salute (MoH)
Dir. Public Health and Prevention
V Martini, MG Pompa
Dir. Veterinary Public Health and Food Safety
S Guizzardi, B Cappelletti, R Lena, V Martini, M Massaro, A Menghi, D
Monteleone, S Borrello
Istituto Zooprofilattico della Lombardia e Emilia Romagna (IZSLER)
MN Losio, E Pavoni, G Varisco
E Severi, J Takkinen, L Tavoschi (ECDC-FWD)
J Richardson, O Mosbach-Schulz (EFSA)
J. Baele, K Kostenzer (EU Commission)
L Verhoef (RIVM, Bilthoven, The Netherlands),
L De Castelli (IZSPLV, Turin, Italy)
G Squintani, M Friedel (Regione Emilia-Romagna, Bologna, Italy)
F Lo Monte (USL3 Toscana, Pistoia, Italy)
Editor's Notes
Prolonged, community-wide outbreak
Risk based sampling of frozen berries
EI = epidemic intelligence, progetto nostro ma dal quale spesso captiamo segnali su epidemie ed altre info rilevanti sulle CD